September 28 | 3 p.m. CET | 9 a.m. EST| Speaker: Dr. Yordan Sbirkov
Chief Assistant Professor
Medical University of Plovdiv, Bulgaria
As few as 0.1% of all drugs make it from bench to bedside, significantly impacted by the poor predictive models available during pre-clinical and clinical phases of drug testing. Dr. Sbirkov and his colleagues are looking to improve success rates and bring novel treatments for colorectal cancer by developing superior disease models that capture in vivo conditions closer, possess higher predictive properties, and offer opportunities for individualized therapies.
In this webinar Dr. Sbirkov will discuss: